Navigation Links
Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market

BOSTON, Sept. 4, 2012 /PRNewswire-USNewswire/ -- Tufts Medical Center announced today that it will host its inaugural INNOVATION Day on Wednesday September 12, 2012, from 1:00 p.m. – 5:30 p.m. in the Tufts Medical Center Wolff Auditorium in Boston.  Investors are invited to attend the Forum, which will highlight the groundbreaking and commercially relevant translational research and development being conducted at the Medical Center.

INNOVATION Day, sponsored by the Office of the Chief Scientific Officer, will feature ten sessions led by life science, medical device, and healthcare information technology innovators from the Medical Center who are translating cutting-edge research into products, services, and technology to improve healthcare.

"The Tufts Medical Center research enterprise is pioneering initiatives that have the potential for far reaching impact and advancement for the healthcare landscape," said Chief Scientific Officer Dick Karas. "INNOVATION Day will give some of the industry's best and brightest the opportunity to showcase the technological advances, innovations and products resulting from this work across all facets of the medical industry."   

"Innovation Day provides a significant platform to reveal the latest scientific breakthroughs and product development that comes from the Tufts Medical Center research enterprise," said Jill Maron, M.D., MPH, Investigator at the Mother Infant Research Institute (MIRI).  "The NOuRISH platform developed at MIRI as a result of intensive research, will help doctors determine when it is safe to start transitioning premature babies to oral feeding.  This, along with other product developments, has the potential to greatly improve the quality of care provided to patients."

Keynote: The Power of Two in Bringing New Medicines to Patients Patrice Milos, Ph.D., Site Head Boston – Pfizer, Centers for Therapeutic Innovation

Session One: Endoglin: a Novel Peptide for Cardiovascular Applications Navin Kapur, M.D., Investigator, Molecular Cardiology Research Institute (MCRI)

Session Two: Injectable, Silk-based Biomaterial Device for Preterm Birth Prevention Michael House, M.D., Investigator, Mother Infant Research Institute (MIRI)

Session Three: The NOuRISH Platform™: Neonatal Oral-feeding Readiness in Salivary High Throughput Diagnostics Jill Maron, M.D., MOH, Investigator, Mother Infant Research Institute (MIRI)

Session Four: Medical Device Innovation for Anesthesia: PZ Airway Pei-Shan Zhao, M.D., Department of Anesthesiology

Session Five: Health Economics and Coverage Databases Peter Neumann, ScD, Director of Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies

Session Six: Reducing the Human and Economic Burden of Depression in the Workplace via Healthcare Services/IT Initiative Debra Lerner, MS Ph.D., Director, Program on Health, Work and Productivity, Institute for Clinical Research and Health Policy Studies

Session Seven: "Best-Fit Scheduling ™": Clinical Flow Optimization for Inpatient Laboratory and Procedure Areas Marvin A. Konstam, M.D., Director, Cardiovascular Center

Session Eight: Development of Angiogenin Protein as a Novel Therapeutic for Amyotrophic Lateral Sclerosis (ALS) Guofu Hu, Ph.D., Investigator, Molecular Oncology Research Institute (MORI)

Session Nine: A Novel PAR2 Pepducin for Dermatologic Applications Athan Kuliopulos, M.D., Ph.D., Investigator, Molecular Oncology Research Institute (MORI)

Session Ten: ROMPeR™ A Clinical Mobile System for Radiation Therapy Performance Excellence David E. Wazer, M.D., Radiation Oncologist-in-Chief, Department of Radiation Oncology

A reception to meet the presenters will follow the forum, which will provide an opportunity for the investment community to meet leading healthcare entrepreneurs.

Innovation Day 2012
Wednesday, September 12, 2012
1:00 p.m. – 5:30 p.m.
Wolff Auditorium, Tufts Medical Center
800 Washington Street, Boston, MA

About Tufts Medical Center and Floating Hospital for Children
Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and the Floating Hospital for Children. Conveniently located in downtown Boston, the Medical Center houses four research institutes and is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with seven community hospitals and with New England Quality Care Alliance, its community physicians' network.

SOURCE Tufts Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
2. DiaTech Life Sciences Announces Medical Advisory Board
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
6. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):